Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-15T19:42:13.707Z Has data issue: false hasContentIssue false
  • English
  • Français

The Economics of Home Care for the Treatment of End-Stage Renal Failure

Published online by Cambridge University Press:  10 March 2009

Anne Ludbrook
Anne Ludbrook
Affiliation:
University of Aberdeen
Get access Rights & Permissions [Opens in a new window]

Extract

Economic appraisals of health care come in various forms and tackle different questions. A treatment is worth providing, in economic terms, if the benefits it produces outweigh the costs of provision. New treatments and methods of delivery should be substituted for old ones if they allow more patients to be treated for the same cost, or the same patients at less cost. These are the basic issues which cost benefit and cost-effectiveness analyses address.

Type
Advanced Technology and Health Care in the Home
Information
International Journal of Technology Assessment in Health Care , Volume 1 , Issue 2 , April 1985 , pp. 315 - 324
Copyright
Copyright © Cambridge University Press 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Ludbrook, A.A cost-effectiveness analysis of the treatment of chronic renal failure. Applied Economics, 1981, 13, 337–350.CrossRefGoogle Scholar
2.Mancini, P. V. and Davis, M. J. S.The costs of renal replacement therapy. Department of Health and Social Security Economic Advisers Office, London, 1982 (mimeo).Google Scholar
3.Buxton, M. J. and West, R. R.Cost-benefit analysis of long-term haemodialysis for chronic renal failure. British Medical Journal, 1975, 2, 376–379.CrossRefGoogle ScholarPubMed
4.Stange, P. V. and Sumner, A. T.Predicting treatment costs and life expectancy for end-stage renal disease. New England Journal of Medicine, 1978, 298, 372–378.CrossRefGoogle ScholarPubMed
5.Roberts, S. D., Maxwell, D. R., and Gross, T. L.Cost-effective care of end stagerenal disease: a billion dollar question. Annals of Internal Medicine, 1980, 92, 243–248.CrossRefGoogle Scholar
6.Lameire, N. H.Reflections on the status of treatment of end-stage renal disease in Belgium. The Renal Family, 5, 18–22.Google Scholar
7.George, C. R. P.Feasibility of universal home haemodialysis with simplified techniques. Lancet, 1983, 2, 895–897.CrossRefGoogle ScholarPubMed
8.European Dialysis and Transplant Association. Combined report on regular dialysis and transplantation in Europe, XIII, 1982. EDTA, London, 1983.Google Scholar
9.Oreopoulos, D. G.The coming of age of continuous ambulatory peritoneal dialysis (CAPD). Dialysis and Transplantation, 1979, 8, 460–461, 517.Google Scholar
10.Banester, H. K., Driscoll, R. D., Greenwood, R. N., and Cathell, W. R.Reuse of haemodialysis equipment: convenience and cost-effectiveness. British Medical Journal, 1982, 285, 473–474.CrossRefGoogle ScholarPubMed